Medications That May Detrimentally Affect Bone Health

24.09.2012

As health declines, senior adults are often made susceptible to several chronic illnesses that may require the use of prescription medications for a long term basis, health experts say. Although these drugs may have numerous benefits, they may also carry their own risks that may be detrimental to the bones. Ageing men and women enduring a chronic illness may be prescribed of several medications including bisphosphonates as essential treatment to bone loss. However, as were other medications, bone-sparing drugs like Fosamax may also carry the risk of adverse events that may be a potential source of added health concern of a patient.

Even if they are prescribed as treatment to another disease, a number of medications may bring about harm to bone health that may potentially lead to osteoporosis. One of the most commonly used prescription medications that may have a detrimental relation to osteoporosis are steroids.

Corticosteroids, commonly known as steroids, are often prescribed as therapy to health conditions that involve inflammation such as asthma, rheumatoid arthritis, and lupus, medical experts say. People who may be under steroid therapy for a longer duration (six months or more) have a greater risk of developing steroid-induced osteoporosis.

Anti-seizure medications may also impact bone health. As anticonvulsants, these drugs may interfere with the liver’s ability to metabolize vitamin D which regulates the absorption of calcium – two nutrients that play a major role for better bone health.

Women who may have been prescribed of aromatase inhibitors – a class of drugs commonly used as treatment in patients with breast cancer – may also stand at a greater risk of extremely weak bones. This group of drugs may limit the amount of estrogen levels left in the body, female hormones that play a protective role to bones which are known to significantly reduce in number while women go through their peri- and postmenopausal phase.

Patients suffering from gastroesophageal reflux disease (GERD), a recurrent digestive disease marked by heartburn, are often prescribed with proton pump inhibitors. The United States Food and Drug Administration released a safety warning in 2010 pertaining to proton pump inhibitors’ potential to raise a patient’s risk of broken wrist, spine, and hip when taken in higher dosage and used for a prolonged period.

Health experts advise patients to work a collaborative effort with their primary care provider and increase conversation as regard the risk and benefits of a certain medication, and how it may affect bone health.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sources:

webmd.com/osteoporosis/bone-health-12/medication-affect-bones?page=1

nhs.uk/conditions/Corticosteroid-(drugs)/Pages/Introduction.aspx

medschool.creighton.edu/fileadmin/user/medicine/Departments/Medicine/Endocrinology/ORC/23_Newsletter.pdf

reuters.com/article/2012/07/25/us-steroids-worry-idUSBRE86O1MU20120725

webmd.com/breast-cancer/aromatase-inhibitors-for-breast-cancer

fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm213206.htm

{ 0 коментара… прибавете свой сега }

Оставете коментар

Previous post:

Next post: